Registration and Informed Consent Study for the Childhood Cancer Research Network
Protocol for Registration and Consent to the Childhood Cancer Research Network - A Limited Institution Pilot
2 other identifiers
interventional
2,242
2 countries
21
Brief Summary
RATIONALE: Collecting informed consent from parents of children with cancer to register with the Childhood Cancer Research Network may help the study of cancer in the future. PURPOSE: This study is collecting informed consent to register younger patients with cancer into the Childhood Cancer Research Network.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started May 2001
Longer than P75 for not_applicable
21 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2001
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2007
CompletedFirst Submitted
Initial submission to the registry
February 9, 2007
CompletedFirst Posted
Study publicly available on registry
February 12, 2007
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2011
CompletedJune 27, 2013
June 1, 2013
5.7 years
February 9, 2007
June 26, 2013
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Informed consent collection to register with the Childhood Cancer Research Network
Informed consent collection for possible participation in future non-therapeutic research studies
Facilitation of systematic registration into the Childhood Cancer Research Network
Study Arms (3)
Stratum 1: No Consent for personal identification
EXPERIMENTALData to be collected for this stratum include histology, primary site, treating hospital, and institutional principal investigator. Data will be coded using the North American Association for Central Cancer Registries (N.A.A.C.C.R.) data standards for cancer registries.
Stratum 2: Consent for personal identification - No Contact
EXPERIMENTALData will be collected for this study include:child's name, parent's name, address, telephone number, child's date of birth, race, ethnicity, histology, primary site, treating hospital, and institutional principal investigator. Data will be coded using the North American Association for Central Cancer Registries (N.A.A.C.C.R.) data standards for cancer registries. No contact for future to ask me to consider taking part in Research Network approved studies
Stratum 3: Consent for personal identification - Contact
EXPERIMENTALData will be collected for this study include:child's name, parent's name, address, telephone number, child's date of birth, race, ethnicity, histology, primary site, treating hospital, and institutional principal investigator. Data will be coded using the North American Association for Central Cancer Registries (N.A.A.C.C.R.) data standards for cancer registries Someone from the Childhood Cancer Research Network may contact me in the future to ask me to consider taking part in Research Network approved studies
Interventions
Eligibility Criteria
Contact the study team to discuss eligibility requirements. They can help determine if this study is right for you.
Sponsors & Collaborators
- Children's Oncology Grouplead
- National Cancer Institute (NCI)collaborator
Study Sites (21)
Jonathan Jaques Children's Cancer Center at Miller Children's Hospital
Long Beach, California, 90801, United States
Carole and Ray Neag Comprehensive Cancer Center at the University of Connecticut Health Center
Farmington, Connecticut, 06360-2875, United States
Lee Cancer Care of Lee Memorial Health System
Fort Myers, Florida, 33901, United States
University of Florida Shands Cancer Center
Gainesville, Florida, 32610-0232, United States
Cancer Research Center of Hawaii
Honolulu, Hawaii, 95813, United States
Advocate Lutheran General Cancer Care Center
Park Ridge, Illinois, 60068-1174, United States
Breslin Cancer Center at Ingham Regional Medical Center
Lansing, Michigan, 48910, United States
Children's Hospitals and Clinics of Minneapolis
Minneapolis, Minnesota, 55404, United States
Norris Cotton Cancer Center at Dartmouth-Hitchcock Medical Center
Lebanon, New Hampshire, 03756-0002, United States
Hackensack University Medical Center Cancer Center
Hackensack, New Jersey, 07601, United States
Albany Medical Center Hospital
Albany, New York, 12208-3419, United States
NYU Cancer Institute at New York University Medical Center
New York, New York, 10016, United States
Mission Hospitals - Memorial Campus
Asheville, North Carolina, 28801, United States
Children's Medical Center - Dayton
Dayton, Ohio, 45404-1815, United States
Tod Children's Hospital - Forum Health
Youngstown, Ohio, 44501, United States
St. Christopher's Hospital for Children
Philadelphia, Pennsylvania, 19134-1095, United States
East Tennessee Children's Hospital
Knoxville, Tennessee, 37916, United States
Driscoll Children's Hospital
Corpus Christi, Texas, 78466, United States
Fletcher Allen Health Care - University Health Center Campus
Burlington, Vermont, 05405, United States
University of Alberta Hospital
Edmonton, Alberta, T6G 1Z2, Canada
Montreal Children's Hospital at McGill University Health Center
Montreal, Quebec, H3H 1P3, Canada
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Julie A. Ross, PhD
Masonic Cancer Center, University of Minnesota
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- NETWORK
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 9, 2007
First Posted
February 12, 2007
Study Start
May 1, 2001
Primary Completion
January 1, 2007
Study Completion
January 1, 2011
Last Updated
June 27, 2013
Record last verified: 2013-06